Form 8-K - Current report:
SEC Accession No. 0000917520-20-000054
Filing Date
2020-12-16
Accepted
2020-12-16 08:13:55
Documents
15
Period of Report
2020-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20201215.htm   iXBRL 8-K 41853
2 EX-99.1 pressreleasedecember162020.htm EX-99.1 15200
  Complete submission text file 0000917520-20-000054.txt   231866

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20201215.xsd EX-101.SCH 2492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT iart-20201215_cal.xml EX-101.CAL 777
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20201215_def.xml EX-101.DEF 14639
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20201215_lab.xml EX-101.LAB 28209
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20201215_pre.xml EX-101.PRE 15146
8 EXTRACTED XBRL INSTANCE DOCUMENT iart-20201215_htm.xml XML 10538
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 201391337
SIC: 3841 Surgical & Medical Instruments & Apparatus